{
  "abstract": "Managing geriatric patients on antiplatelet therapy after a fall presents a significant clinical challenge. Although research has often focused on aspirin,1 the risks associated with P2Y12 inhibitors or dual antiplatelet therapy (DAPT) remain less clear. A pivotal study by Wang et al now offers insights into this dilemma. In their prospective study of 3709 patients, Wang et al present a landmark finding: although preinjury use of aspirin and DAPT is associated with increased odds of intracranial hemorrhage (ICH), use of Adenosine diphosphate receptor inhibitor (P2Y12) inhibitors such as clopidogrel are not.2",
  "authors": [
    {
      "affiliations": [
        "Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA",
        "Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA"
      ],
      "name": "Jace Bradshaw"
    },
    {
      "affiliations": [
        "Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA"
      ],
      "name": "Joshua D Niforatos"
    }
  ],
  "title": "Unequal risks, unchanged practice: antiplatelet therapy and head imaging after geriatric falls",
  "uid": "da7c915c-7312-5ec3-bffb-c0eda79a7754"
}